Home › Funds › VAUGHAN & Co SECURITIES, INC. › GSK

VAUGHAN & Co SECURITIES, INC. position in GSK

GSK PLC · Health Care

VAUGHAN & Co SECURITIES, INC. reported holding 13,618 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$656K, representing 0.31% of its reported portfolio and ranking #32 among its reported holdings. VAUGHAN & Co SECURITIES, INC. has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.62K sh
Reported value held$655.98K
Portfolio Weight0.31%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VAUGHAN & Co SECURITIES, INC.'s GSK position evolved

VAUGHAN & Co SECURITIES, INC. first disclosed a stake in GSK in Q3 2023 at 16,989 shares (US$616K). The position peaked in Q1 2026 at 16,873 shares, worth US$931K. Across 13 filings, VAUGHAN & Co SECURITIES, INC. increased the stake 2 time(s), trimmed it 7 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 13,618 shares valued at US$656K — a reduction of -2,613 shares quarter over quarter.. Notable position changes include a 35% increase in Q1 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.99K $615.85K New
Q4 2023 16.46K $610.01K Reduce
Q1 2024 14.63K $627.32K Reduce
Q2 2024 14.02K $539.65K Reduce
Q3 2024 13.96K $570.77K Hold
Q4 2024 13.90K $470.20K Hold
Q1 2025 18.71K $724.75K Add
Q2 2025 18.64K $715.74K Hold
Q3 2025 19.02K $820.82K Add
Q4 2025 17.66K $865.90K Reduce
Q1 2026 16.87K $931.22K Reduce
Q2 2026 16.23K $850.83K Reduce
Q3 2026 13.62K $655.98K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 20 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has VAUGHAN & Co SECURITIES, INC. held GSK?

VAUGHAN & Co SECURITIES, INC. has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VAUGHAN & Co SECURITIES, INC.'s current position in GSK?

As of Q3 2026, VAUGHAN & Co SECURITIES, INC. holds 13.62K shares of GSK (GSK PLC), valued at $655.98K, representing 0.31% of its reported portfolio and ranking #32.

Has VAUGHAN & Co SECURITIES, INC. been buying or selling GSK?

In the latest 13F filing (Q3 2026), VAUGHAN & Co SECURITIES, INC. reduced its position in GSK. The position peaked in Q1 2026 at 16.87K shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.